Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Eur Urol. 2014 Sep 30;67(4):649–657. doi: 10.1016/j.eururo.2014.09.020

Table 1. Top 40 SNPs in BPC3 and associations with aggressive prostate cancer in BPC3, PRACTICAL, and random-effects meta-analysis.

SNP Alleles Region Trait in GWAS catalog BPC3 PRACTICAL Meta-analysis
OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value phet I2 (%)
rs7014346 A vs G 8q24.21 Colorectal cancer 1.19 (1.11–1.28) 1.60 × 10−6 1.22 (1.16–1.29) 3.49 × 10−13 1.21 (1.16–1.27) 3.22 × 10−18 0.64 0
rs6569648 C vs T 6q23.1 Height 0.86 (0.79–0.93) 3.08 × 10−4 0.97 (0.91–1.04) 4.16 × 10−1 0.92 (0.81–1.04) 0.175 0.02 82.8
rs2687720a A vs G 3q21.3 Menarche (age at onset) 1.15 (1.07–1.24) 3.48 × 10−4 1.09 (1.03–1.16) 4.02 × 10−3 1.11 (1.06–1.17) 6.74 × 10−5 0.26 19.8
rs10505477 C vs T 8q24.21 Colorectal cancer 0.85 (0.77–0.93) 4.15 × 10−4 0.79 (0.75–0.83) 7.72 × 10−20 0.81 (0.76–0.86) 3.56 × 10−11 0.21 35.4
rs9318086 A vs G 13q12.12 Myopia 1.13 (1.06–1.22) 4.53 × 10−4 1.01 (0.96–1.06) 7.38 × 10−1 1.07 (0.95–1.20) 2.65 × 10−1 <0.01 85.2
rs753955 T vs C 13q12.12 Lung cancer 1.14 (1.06–1.22) 4.60 × 10−4 1.03 (0.98–1.09) 2.74 × 10−1 1.08 (0.98–1.19) 1.18 × 10−1 0.03 77.9
rs3180018 A vs G 1q22 Crohn disease 1.16 (1.07–1.25) 5.15 × 10−4 0.99 (0.93–1.05) 7.47 × 10−1 1.07 (0.92–1.24) 4.02 × 10−1 <0.01 88.7
rs10069690 C vs T 5p15.33 Breast cancer 1.21 (1.08–1.35) 6.10 × 10−4 1.20 (1.13–1.28) 3.45 × 10−9 1.21 (1.14–1.27) 8.82 × 10−12 0.97 0
rs6910071 G vs A 6p21.32 Rheumatoid arthritis 1.16 (1.06–1.27) 8.53 × 10−4 1.02 (0.96–1.09) 5.67 × 10−1 1.08 (0.95–1.23) 2.16 × 10−1 0.02 81.8
rs7788750a T vs C 7q22.1 Ulcerative colitis 1.36 (1.13–1.63) 9.83 × 10−4 0.88 (0.76–1.00) 5.39 × 10−2 1.09 (0.71–1.67) 7.10 × 10−1 <0.01 93.1
rs2315008 T vs G 20q13.33 Inflammatory bowel disease 0.88 (0.82–0.95) 1.15 × 10−3 0.86 (0.81–0.91) 1.45 × 10−7 0.87 (0.83–0.91) 7.43 × 10−10 0.57 0
rs6756629 A vs G 2p21 Total and LDL cholesterol 1.26 (1.09–1.44) 1.20 × 10−3 0.96 (0.86–1.07) 4.49 × 10−1 1.09 (0.84–1.42) 5.07 × 10−1 <0.01 89
rs4809330 A vs G 20q13.33 Crohn disease 0.88 (0.82–0.95) 1.21 × 10−3 0.86 (0.81–0.91) 1.77 × 10−7 0.87 (0.83–0.91) 9.50 × 10−10 0.57 0
rs3764021 A vs G 12p13.31 Type 1 diabetes 0.89 (0.82–0.95) 2.04 × 10−3 1.02 (0.97–1.07) 4.91 × 10−1 0.95 (0.83–1.09) 4.91 × 10−1 <0.01 88.3
rs10229583 A vs G 7q32.1 Type 2 diabetes 1.14 (1.05–1.23) 2.10 × 10−3 1.02 (0.96–1.08) 5.45 × 10−1 1.07 (0.96–1.19) 1.99 × 10−1 0.04 77.4
rs968451 T vs G 22q13.1 Primary biliary cirrhosis 1.15 (1.05–1.26) 2.24 × 10−3 1.02 (0.95–1.09) 5.82 × 10−1 1.08 (0.96–1.21) 2.10 × 10−1 0.04 77.5
rs12563627a T vs C 1q22 Inflammatory bowel disease 1.12 (1.04–1.21) 2.61 × 10−3 1.02 (0.96–1.08) 5.20 × 10−1 1.07 (0.97–1.17) 1.91 × 10−1 0.04 75.9
rs10466829 G vs A 12p13.31 Multiple sclerosis 1.11 (1.04–1.20) 2.69 × 10−3 0.99 (0.94–1.04) 6.52 × 10−1 1.05 (0.93–1.18) 4.50 × 10−1 <0.01 85.7
rs8079702 G vs A 17q24.3 Primary tooth development (number of teeth) 1.11 (1.04–1.20) 3.02 × 10−3 0.96 (0.91–1.01) 1.40 × 10−1 1.03 (0.89–1.19) 6.69 × 10−1 <0.01 90.6
rs2048327 G vs A 6q25.3 Coronary heart disease 1.12 (1.04–1.20) 3.06 × 10−3 1.05 (1.00–1.11) 5.69 × 10−2 1.08 (1.02–1.14) 6.00 × 10−3 0.22 33.4
rs4905994a T vs C 14q32.2 Platelet counts 1.12 (1.04–1.21) 3.37×10−3 0.96 (0.91–1.02) 1.83×10−1 1.04 (0.89–1.20) 6.42 × 10−1 <0.01 89.9
rs7901695 C vs T 10q25.2 Type 2 diabetes 0.89 (0.83–0.96) 3.67 × 10−3 1.00 (0.94–1.06) 9.89 × 10−1 0.95 (0.85–1.06) 3.39 × 10−1 0.02 81.4
rs3846662 C vs T 5q13.3 Total and LDL cholesterol 0.90 (0.84–0.97) 4.04 × 10−3 1.04 (0.98–1.10) 1.71 × 10−1 0.97 (0.85–1.11) 6.58 × 10−1 <0.01 89.7
rs625658a A vs C 1q22 Inflammatory bowel disease 1.12 (1.04–1.20) 4.05 × 10−3 1.02 (0.97–1.08) 4.87 × 10−1 1.06 (0.97–1.16) 1.73 × 10−1 0.06 72.1
rs6569992 A vs G 6q23.3 Red blood cell traits 0.88 (0.80–0.96) 4.24 × 10−3 0.93 (0.87–1.00) 5.68 × 10−2 0.91 (0.86–0.96) 1.00 × 10−3 0.32 100
rs10033464 T vs G 4q25 Atrial fibrillation 1.19 (1.06–1.33) 4.25 × 10−3 0.95 (0.87–1.04) 2.69 × 10−1 1.06 (0.85–1.31) 6.07 × 10−1 <0.01 88.5
rs1562990 C vs A 11q12.2 Alzheimer disease 1.11 (1.03–1.19) 5.05 × 10−3 1.02 (0.96–1.07) 5.35 × 10−1 1.06 (0.97–1.15) 1.86 × 10−1 0.06 71.4
rs4869272a C vs T 5q15 Fasting glucose-related traits 1.11 (1.03–1.20) 5.33 × 10−3 1.01 (0.95–1.08) 7.49 × 10−1 1.06 (0.96–1.17) 2.34 × 10−1 0.06 71.7
rs7903146 T vs C 10q25.2 Type 2 diabetes; Fasting glucose-related traits; Fasting insulin-related traits; Proinsulin levels; HbA1c levels 0.89 (0.83–0.97) 5.40 × 10−3 1.00 (0.94–1.06) 9.64 × 10−1 0.95 (0.85–1.06) 3.33 × 10−1 0.03 79.3
rs2970818 T vs A 12p13.32 Phosphorus levels 0.83 (0.73–0.95) 5.42 × 10−3 0.98 (0.89–1.07) 6.26 × 10−1 0.91 (0.77–1.06) 2.31 × 10−1 0.05 75.1
rs16844874a C vs T 2q34 Glycine 1.16 (1.05–1.29) 5.44 × 10−3 1.11 (1.04–1.18) 2.18 × 10−3 1.12 (1.06–1.19) 4.67 × 10−5 0.46 0
rs4374383 A vs G 2q13 Hepatitis C–induced liver fibrosis 1.11 (1.03–1.19) 5.63 × 10−3 1.00 (0.93–1.07) 9.20 × 10−1 1.05 (0.95–1.17) 3.56 × 10−1 0.04 76.7
rs9900242a A vs G 17q24.3 Pulmonary function in smokers 0.90 (0.84–0.97) 5.67 × 10−3 0.90 (0.85–0.95) 1.39 × 10−4 0.90 (0.86–0.94) 2.50 × 10−6 0.94 0
rs9303521 T vs G 17q21.31 Bone mineral density 0.90 (0.84–0.97) 5.42 × 10−3 0.99 (0.94–1.04) 6.26 × 10−1 0.95 (0.87–1.04) 2.35 × 10−1 0.05 74.1
rsl0804533a T vs C 3ql3.32 Menarche (age at onset) 0.91 (0.85–0.97) 5.93 × 10−3 1.04 (0.98–1.09) 1.93 × 10−1 0.97 (0.85–1.11) 6.57 × 10−1 <0.01 88.7
rsl0757274 A vs G 9p21.3 Coronary heart disease 0.91 (0.85–0.97) 6.64 × 10−3 1.03 (0.98–1.09) 2.31 × 10−1 0.97 (0.85–1.10) 6.39 × 10−1 <0.01 88
rsl 6948098 A vs G 15ql5.3 Serum albumin level 0.79 (0.66–0.94) 5.42 × 10−3 0.94 (0.81–1.08) 6.26 × 10−1 0.87 (0.73–1.03) 9.80 × 10−2 0.13 56.8
rs944797 CvsT 9p21.3 Coronary heart disease 1.10(1.03–1.18) 7.01 × 10−3 0.97 (0.92–1.03) 2.89 × 10−1 1.03 (0.91–1.17) 6.11 × 10−1 <0.01 87.2
rsl0757278 G vs A 9p21.3 Myocardial infarction 1.11 (1.03–1.19) 5.42 × 10−3 0.98 (0.93–1.03) 6.26 × 10−1 1.04(0.92–1.17) 5.60 × 10−1 <0.01 86.2
rs9510787 G vs A 13ql2.12 Nasopharyngeal carcinoma 1.11 (1.03–1.21) 7.18 × 10−3 1.00(0.94–1.07) 9.82 × 10−1 1.05 (0.95–1.17) 3.47 × 10−1 0.04 77.5

BPC3 = Breast and Prostate Cancer Cohort Consortium; HbAlc = glycated hemoglobin; LDL = low-density lipoprotein; OR = odds ratio; CI = confidence interval; PRACTICAL = Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome; SNP = single-nucleotide polymorphism; GWAS = genome-wide association studies; phet = p value for Cochran's Q statistic for between-study heterogeneity.

Logistic regression was applied in BPC3 and PRACTICAL. Meta-analysis was performed under a random-effects model. All ORs are per-copy of the first allele shown in the Alleles column.

a

These SNPs are correlated with GWAS catalog-indexed SNPs not found in BPC3 per se as follows: rs9900242 and rsl 1654749 (r2 = 0.93, D′ = 1); rs2687720 and rs2687729 (r2 = 1, D′ = l), rsl0804533 and rs6438424 (r2 = 1, D′ = 1), rs7788750 and rs7809799 (r2 = 1, D′ = 1), rsl2563627 and rs670523 (r2 = 0.97, D′ = 1), rs4905994 and rs7149242 (r2 = 0.96, D′ = 1), rs625658 and rs670523 (r2 = 1, D′ = 1), rsl6844874 and rs2216405 (r2 = 0.94, D′ = 1), rs4869272 and rsl3179048 (r2 = 1, D′ = 1).